CSI Market
Sign In | Register

Innovation1 Biotech Inc (MYYZ) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MYYZ Annual Balance Sheets →
This page allows investors to track Innovation1 Biotech Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Feb 29 2024)
(Nov 30 2023) (Aug 31 2023) (May 31 2023) (Feb 28 2023)
Assets
Cash & cash equivalent0.11
Cash, Cash Equivalents Other0.00
Cash & Short-term Investments0.00
Accounts receivable0.00
Other Receivables0.00
Other Current Assets0.00
Total loans net0.01
Total Current Assets0.12
Equipment/Property/Plant Net0.00
Intangible Assets0.00
Long-term investments0.00
Other Assets, Noncurrent0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill-
Total Assets0.12
Liabilities
Accounts Payable0.35
Accrued Liabilities, Current0.18
Short-term Debt0.01
Other Liabilities, Current2.36
Total Current Liabilities2.90
Long-term Debt Convertible0.56
Total Long-term Debt0.56
Accrued Expenses Related Parties0.11
Total Liabilities3.46
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock56.20
Retained Earnings / Accumulated Deficit-59.57
Other Equity0.01
Common Stockholder's Equity-3.34
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-3.34
Liabilities & Stockholder's Equity0.12
4 historic quarters locked

Sign in to unlock the full Innovation1 Biotech Inc balance sheet history.

Sign In Create Free Account

About Innovation1 Biotech Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240229)
  • Filed with the SEC: May 6, 2025
  • Source: g084799_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001753926-25-000753

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.